Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Peter, Ivak"'
Autor:
Barbora Judita Kasperova, Milos Mraz, Petr Svoboda, Daniel Hlavacek, Helena Kratochvilova, Istvan Modos, Nikola Vrzackova, Peter Ivak, Petra Janovska, Tatyana Kobets, Jakub Mahrik, Martin Riecan, Lenka Steiner Mrazova, Viktor Stranecky, Ivan Netuka, Tomas Cajka, Ondrej Kuda, Vojtech Melenovsky, Sona Stemberkova Hubackova, Martin Haluzik
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are glucose-lowering agents used for the treatment of type 2 diabetes mellitus, which also improve heart failure and decrease the risk of cardiovascular complications. Epicardial
Externí odkaz:
https://doaj.org/article/f5b7b9bcaae44ad086f3948fb34547db
Autor:
Zuzana Tucanova, Peter Ivak, Peter Wohlfahrt, Marek Pol, Daniel Hlavacek, Miroslav Konarik, Ondrej Szarszoi, Ivan Netuka, Jan Pitha
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4288-4295 (2021)
Abstract Aims Recipients of left ventricular assist devices (LVAD) are exposed to increased risk of adverse clinical events. One of the potential contributing factors is non‐pulsatile flow generated by LVAD. We evaluated the association of flow pat
Externí odkaz:
https://doaj.org/article/710e3f13c191446cac6d34c8cb366b62
Autor:
Fausto Biancari, Giovanni Mariscalco, Hakeem Yusuff, Geoffrey Tsang, Suvitesh Luthra, Francesco Onorati, Alessandra Francica, Cecilia Rossetti, Andrea Perrotti, Sidney Chocron, Antonio Fiore, Thierry Folliguet, Matteo Pettinari, Angelo M. Dell’Aquila, Till Demal, Lenard Conradi, Christian Detter, Marek Pol, Peter Ivak, Filip Schlosser, Stefano Forlani, Govind Chetty, Amer Harky, Manoj Kuduvalli, Mark Field, Igor Vendramin, Ugolino Livi, Mauro Rinaldi, Luisa Ferrante, Christian Etz, Thilo Noack, Stefano Mastrobuoni, Laurent De Kerchove, Mikko Jormalainen, Steven Laga, Bart Meuris, Marc Schepens, Zein El Dean, Antti Vento, Peter Raivio, Michael Borger, Tatu Juvonen
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the
Externí odkaz:
https://doaj.org/article/9c01ea761fb54a90b7244e0a0628e42d
Autor:
Christophe, Peronino, Coralie L, Guerin, Peter, Ivak, Léa, Guyonnet, Richard, Chocron, Grégoire, Detriché, Christian, Latremouille, Maxime, Gruest, Aurélien, Philippe, Antoine, Capel, Yuri, Pya, Anne-Céline, Martin, Piet, Jansen, Nicolas, Gendron, Ivan, Netuka, David M, Smadja
Publikováno v:
ASAIO Journal. 68:e173-e178
The Aeson total artificial heart (A-TAH) has been developed for patients at risk of death from biventricular failure. We aimed to assess the inflammatory status in nine subjects implanted with the A-TAH in kinetics over one year. Laboratory assessmen
Autor:
David M. Smadja, Peter Ivak, Yuri Pya, Christian Latremouille, Finn Gustafsson, Jean Christian Roussel, Andre Vincentelli, Erwan Flecher, Piet Jansen, Ivan Netuka
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:1214-1217
Autor:
Fausto Biancari, Giovanni Mariscalco, Hakeem Yusuff, Geoffrey Tsang, Suvitesh Luthra, Francesco Onorati, Alessandra Francica, Cecilia Rossetti, Andrea Perrotti, Sidney Chocron, Antonio Fiore, Thierry Folliguet, Matteo Pettinari, Angelo M. Dell’Aquila, Till Demal, Lenard Conradi, Christian Detter, Marek Pol, Peter Ivak, Filip Schlosser, Stefano Forlani, Govind Chetty, Amer Harky, Manoj Kuduvalli, Mark Field, Igor Vendramin, Ugolino Livi, Mauro Rinaldi, Luisa Ferrante, Christian Etz, Thilo Noack, Stefano Mastrobuoni, Laurent De Kerchove, Mikko Jormalainen, Steven Laga, Bart Meuris, Marc Schepens, Zein El Dean, Antti Vento, Peter Raivio, Michael Borger, Tatu Juvonen
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 16, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/80a5cf572b1c40f38012be12a2414b16
Publikováno v:
Biomedical Papers, Vol 160, Iss 4, Pp 518-523 (2016)
Aims: One of the proposed limitations of left ventricular assist device (LVAD) therapy is high degree of sensitization. Apart from human leukocyte antigen (HLA), antibodies against Angiotensin II Type 1 Receptor (AT1R) have been associated with adver
Externí odkaz:
https://doaj.org/article/0cef7d4729284d70b300355b2ef7f504
Autor:
Bastien Poitier, Richard Chocron, Christophe Peronino, Aurélien Philippe, Yuri Pya, Nadia Rivet, Ulysse Richez, Mahabbat Bekbossynova, Nicolas Gendron, Marc Grimmé, Marie Cécile Bories, Julie Brichet, Antoine Capel, Jeanne Rancic, Benoit Vedie, Jean Christian Roussel, Anne-Sophie Jannot, Piet Jansen, Alain Carpentier, Peter Ivak, Christian Latremouille, Ivan Netuka, David M. Smadja
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology, 2022, 42 (4), pp.470-480. ⟨10.1161/ATVBAHA.121.316833⟩
Arterioscler Thromb Vasc Biol
Arteriosclerosis, Thrombosis, and Vascular Biology, 2022, 42 (4), pp.470-480. ⟨10.1161/ATVBAHA.121.316833⟩
Arterioscler Thromb Vasc Biol
Background: Carmat bioprosthetic total artificial heart (Aeson; A-TAH) is a pulsatile and autoregulated device. The aim of this study is to evaluate level of hemolysis potential acquired von Willebrand syndrome after A-TAH implantation. Methods: We e
Autor:
David M. Smadja, Christophe Peronino, Léa Jilet, Peter Ivak, Yuri Pya, Aurélien Philippe, Christian Latremouille, Finn Gustafsson, Faiz Z. Ramjankhan, Jean Christian Roussel, André Vincentelli, Erwan Flecher, Pascale Gaussem, Piet Jansen, Ivan Netuka
IntroductionThe Aeson bioprosthetic total artificial heart (A-TAH) is a pulsatile and autoregulated device. The aim of this study was to evaluate the level of platelet activation secondary to A-TAH implantation.MethodsWe examined the level of platele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d66895b27d582f6425afd1de911c9791
https://doi.org/10.1101/2023.01.20.23284588
https://doi.org/10.1101/2023.01.20.23284588
Autor:
Antoine Capel, Ivan Netuka, Nicolas Gendron, Léa Guyonnet, Christophe Peronino, Piet G.M. Jansen, Lou Soret, David M. Smadja, Coralie L. Guerin, Christian Latremouille, Tristan Mirault, Grégoire Detriche, Alain Carpentier, Aurélien Philippe, Peter Ivak
Publikováno v:
Stem Cell Reviews and Reports. 17:2332-2337
The Aeson® total artificial heart (A-TAH) has been developed as a total heart replacement for patients at risk of death from biventricular failure. We previously described endothelialization of the hybrid membrane inside A-TAH probably at the origin